Apimeds Pharmaceuticals removes director Erik Emerson via stockholder vote

Apimeds Pharmaceuticals US, Inc.

Erik Emerson removed from board of directors effective December 30, 2025.
Removal effected by majority stockholder vote, with or without cause.
Remaining board: Elona Kogan, Jakap Koo, Carol O'Donnell, Dr. Bennett Weintraub.

item 5.02

Source: SEC EDGAR

accession 0001213900-26-000464

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.